Public Attitudes Toward Precision Medicine: A Nationwide Survey on Developing a National Cohort Program for Citizen Participation in the Republic of Korea by 김소윤 & 김한나
fgene-11-00283 May 10, 2020 Time: 19:16 # 1
ORIGINAL RESEARCH

















This article was submitted to
ELSI in Science and Genetics,
a section of the journal
Frontiers in Genetics
Received: 24 October 2019
Accepted: 09 March 2020
Published: 12 May 2020
Citation:
Kim H, Kim HR, Kim S, Kim E,
Kim SY and Park H-Y (2020) Public
Attitudes Toward Precision Medicine:
A Nationwide Survey on Developing a
National Cohort Program for Citizen
Participation in the Republic of Korea.
Front. Genet. 11:283.
doi: 10.3389/fgene.2020.00283
Public Attitudes Toward Precision
Medicine: A Nationwide Survey on
Developing a National Cohort
Program for Citizen Participation in
the Republic of Korea
Hannah Kim1,2, Hye Ryun Kim3, Sumin Kim2, Eugene Kim3, So Yoon Kim1,2* and
Hyun-Young Park3*
1 Division of Medical Law and Ethics, College of Medicine, Yonsei University, Seoul, South Korea, 2 Asian Institute of Bioethics
and Health Law, Yonsei University, Seoul, South Korea, 3 National Biobank of Korea, Center for Genome Science, Korea
National Institute of Health, Cheonju-si, South Korea
This nation-wide survey was conducted among Korean adults to examine the public
interest in and attitudes toward establishing a citizen participation cohort model and
to collect data to support and determine the future policy and research directions of
the Resource Collection Project for Precision Medicine Research (RCP-PMR) before
the project proceeds. The demographic framework of the survey population was
established based on the statistical standards of the Ministry of the Interior and Safety.
An online survey was carried out using web panels between 14 May 2018 and 23
May 2018. Sampling was performed using a simple proportional allocation method
considering region, gender, and age. From this survey, the RCP-PMR received very high
support (94.5%) and the intention to participate was as high as 83.5%. Respondents
had a very positive attitude toward providing their samples and information to the study
(84.5–89.9%). In terms of incentives to participate, respondents wanted to receive health
information (80.2%), monetary compensation (51.4%), and smart devices (41.3%). Most
participants responded that it was appropriate to carry out the project at governmental
research institutes (66.9%). Respondents also had a positive attitude toward sharing
their information and samples as long as it was only shared with the governmental
researchers who run the project (88.0%). However, the survey participants expressed
concerns about the study being time consuming or a hassle (38.1%), privacy breaches
(33.6%), and the lack of returning benefits of participation (25.1%). Participants had
a negative attitude toward sharing their data with researchers who are not directly
involved in the RCP-PMR. Considering the future use of the database derived from
this project, it will be important to communicate with the lay public as well as the
RCP-PMR participants to understand their needs in participating in the forthcoming
study and to improve their understanding of the goals of the project, and how data
sharing can contribute to disease research and prevention. The RCP-PMR should
consider building an efficient citizen-participation program and privacy protection for
the research participants.
Keywords: precision medicine cohorts modeling, participant engagement, public attitude, ELSI, benefits for
participation, data sharing
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INTRODUCTION
Precision medicine aims to understand how a person’s genetics,
environment, and lifestyle can help determine the best approach
to prevent or treat diseases (Collins and Varmus, 2015; Alzu’bi
et al., 2019; Genetics Home Reference, 2019). Precision medicine
integrates advanced technologies with enriched biomedical big
data, including multi-omics; physiological, clinical, mobile, and
remote health; and external environmental information to
provide transformed healthcare services to one or more people
(Collins and Varmus, 2015). For instance, the Precision Medicine
Initiative All of Us Research Program (PMI-AURP) in the
United States collects specimens and a wide range of personal
health information including clinical data, genomic data, and
lifelog data from at least 1 million Americans (National Institutes
of Health, 2019). The 100,000 Genomes Project funded by the
National Institute for Health Research and NHS England involves
sequencing 100,000 genomes, including genomic, phenotypic,
and other clinical data, from 85,000 patients with rare diseases
or cancer (Peplow, 2016; Haga, 2017; Genomics England,
2019). These large-scale precision medicine cohort models
necessitate public participation and collective engagement in
conjunction with longitudinal collection, access, and use of data
(Kaufman et al., 2016).
The Korea Centers for Disease Control & Prevention
(KCDC) is planning to carry out the Resource Collection
Project for Precision Medicine Research (RCP-PMR) from 2020
onward. This project is expected to collect clinical information,
specimens, genetic data, environmental information, and lifelog
data – which are essential for research and technological
development – from individuals who agree to participate
in the RCP-PMR. The collection, storage, and sharing of
individuals’ data are expected to be conducted mainly under
the Personal Information Protection Act and the Bioethics
and Safety Act (Kim et al., 2018). Qualified researchers who
obtain approval to access the database by a proper authority
will be able to use the information to conduct a variety of
biomedical studies.
However, public acceptance of building a citizen participation
national cohort model has not yet been studied in the Republic
of Korea (ROK). In the case of the United States large-scale
prospective cohort, the nationwide precision medicine initiative
cohort study conducted surveys of United States adults to
identify public concerns and problems that had to be addressed
before the study (Kaufman et al., 2016; Okita et al., 2018).
To benchmark a precision medicine cohort program such as
the PMI-AURP, we conducted an Ethical, Legal, and Social
Implications (ELSI) study in the form of a nationwide survey to
confirm public attitude toward precision medicine and to collect
opinions on the RCP-PMR before implementing it. The survey
identified the social acceptance of the specimen and information
Abbreviations: ELSI, Ethical, Legal and Social Implications; IRB, Institutional
Review Board; KCDC, Korea Centers for Disease Control & Prevention; PMI-
AURP, Precision Medicine Initiative All of Us Research Program; RCP-PMR,
Resource Collection Project for Precision Medicine Research; ROK, Republic of
Korea; SNS, Social Networking Sites.




We conducted online surveys to collect basic data for future
policy directions and research by confirming public attitudes
toward and opinions on the RCP-PMR. The online survey
participants were recruited based on the statistics of the resident
registration of the Ministry of the Interior and Safety at the end
of January 2018 (men and women aged 20 and older). Sampling
was performed using a simple proportional allocation method
considering region, gender, and age. The sample selection and
online administration of the survey were managed by the Nielsen
Korea online survey firm. During the field period, 1,500 potential
respondents of at least 20 years old were randomly sampled from
Nielsen’s web-enabled master panel of 500,000 Korean residents.
The survey was fielded online between 14 May 2018 and 23
May 2018 (10 days).
Questionnaire Development
The questionnaire used in this study was developed in
reference to the Kaufman et al. survey (Kaufman et al.,
2016). The questionnaire was written in simple Korean
and included 17 carefully selected multiple-choice questions
about the RCP-PMR and eight items on social/demographic
variables. The KCDC, which leads this precision medicine
national cohort program, provided the draft description of
precision medicine, and the RCP-PMR and the authors
of this paper completed the description by including a
comparison to the PMI-AURP. Respondents answered questions
about precision medicine awareness and then confirmed a
brief description of precision medicine and the RCP-PMR.
Respondents were then asked several questions about the need
for the project, their concerns and willingness to participate in
the project, and the use of their data. See the questionnaire
in the Supplementary Material. After completing the survey,
participants received 4,000 South Korean Won (equivalent of
USD 3.50) for their time.
Ethics Approval
The survey was approved by the Institutional Review Board (IRB)
of the Yonsei University (approval number: Y-2018-0039). Under
the Bioethics and Safety Act, written consent was exempted by
the judge of the IRB because, due to the nature of the survey
form, the respondents should read the survey information before
starting the survey and thus were perceived to have agreed
to participate in the survey. The survey was also designed for
participants to withdraw their own participation at any time
during or after the survey.
Statistical Analysis
Data were analyzed using the IBM SPSS 20 statistical software.
Missing data were excluded by this online survey design.
Respondents’ socio-demographic characteristics were analyzed
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TABLE 1 | Respondents’ characteristics.
Variables N (%)
Gender Men 743 (49.5)
Women 757 (50.5)









Education Less than middle school 46 (3.1)
High school 342 (22.8)
College and more 1,112 (74.1)
Social networking service No use 138 (9.2)
Former use 221 (14.7)
Current use 1,141 (76.1)
using the variables of gender, age, region, household income,
and education (Table 1). In addition, two multiple logistic
regressions were examined (Table 2). The attitude toward the




A total of 52,000 people were invited to participate in the survey
via email and 4,271 connected to the website. Among them, 1,500
people fully responded, resulting in an invitation-response rate
of 2.9% and an access-response rate of 35.1%. The demographic
characteristics of the survey population are shown in Table 1. The
gender distribution was nearly equal, 50.5% female and 49.5%
male. The age ranges were 50–59 (25.9%), 40–49 (20.3%), 60+
(19.1%), 20–29 (17.4%), and 30–39 (17.3%). The distribution
of household income per month in Korean Won (KRW)
was <\2,000,000 (10.2%), \2,000,000 – \3,990,000 (30.5%),
\4,000,000 – \5,990,000 (33.9%), and \6,000,000 ≤ (25.4%). The
education level ranges were less than middle school graduate
(3.1%), high school graduate (22.8%), and college and more
(74.1%). Experience with social networking sites (SNS), such
as Facebook, Twitter, Instagram, and KakaoTalk, were no use
(9.2%), former use (14.7), and current use (76.1%). The margin
of error on opinion estimates based on the sample of 1,500
is ± 2.53% in a 95% confidence interval.
Awareness of Precision Medicine
Participants were asked, “Have you ever heard of precision
medicine?” Of the respondents, 11.5% answered, “I have heard of
it and I know what it is”; 58.2% answered, “I have heard of it, but I
TABLE 2 | Results of two multiple logistic regressions examining socio-demographic variables related to survey participants’ attitude toward the RCP-PMR and their



















Total 1,500 (100) 94.5 83.5
Gender Men 743 (49.5) 95.0 0.197 0.234 0.401 87.6 0.641 0.149 0
Women 757 (50.5) 94.1 ref 79.5 ref
Age 20–29 261 (17.4) 92.7 −0.810 0.334 0.015 78.5 −0.695 0.207 0.001
30–39 259 (17.3) 94.6 −0.474 0.359 0.186 79.9 −0.649 0.208 0.002
40–49 305 (20.3) 93.4 −0.655 0.32 0.041 83.6 −0.404 0.203 0.047
50+ 675 (45.0) 95.7 ref 86.8 ref
Household <\2,000,000 153 (10.2) 90.8 −0.659 0.421 0.117 69.3 −1.311 0.263 <0.0001
Income \2,000,000–
\3,990,000
458 (30.5) 94.5 −0.313 0.353 0.376 79.9 −0.805 0.217 <0.0001
\4,000,000–
\5,990,000
508 (33.9) 94.3 −0.412 0.337 0.222 86 −0.386 0.219 0.078
\6,000,000 ≤ 381 (25.4) 96.3 ref 90.3 ref
Education Less than
middle school
46 (3.1) 84.8 −1.155 0.5 0.021 76.1 −0.272 0.393 0.489
High school 342 (22.8) 95.6 0.249 0.318 0.434 81 −0.066 0.181 0.716
College and
more
1,112 (74.1) 94.6 ref 84.6 ref
Social No use 138 (9.2) 95.3 −0.792 0.338 0.019 84.8 −0.483 0.234 0.039
networking Former use 221 (14.7) 93.7 −0.270 0.314 0.390 81 −0.215 0.196 0.274
service Current use 1,141 (76.1) 89.9 ref 76.8 ref
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FIGURE 1 | Participants’ attitude toward the need to implement the RCP-PMR (A) and their willingness to participate in the study (B).
do not know what it is”; and 30.3% answered, “I have never heard
of it.” Among the 1,046 respondents who have heard of “precision
medicine,” respondents learned about it through media such
as TV and radio (58.9%), the internet (49.8%), magazines and
newspapers (21.5%), and hospitals (13.6%).
After reading the definition and a brief example of precision
medicine, 96.1% responded that precision medicine is important
for prevention and treatment of disease. The higher the education
(less than middle school [89.1%], high school [95.9%], and
college and more [96.4%]) or the higher the household income
(<\2,000,000 [94.8%], \2,000,000 – \3,990,000 [95%], \4,000,000 –
\5,990,000 [96.1%], and \6,000,000 ≤ [97.9%]) of the respondent,
the higher the rating of the importance of precision medicine.
Of the 69.9% of respondents who said they did not know what
precision medicine was before the survey, 91.5% agreed on the
importance of precision medicine.
Attitude Toward the Need to Implement
the RCP-PMR
After introducing the concept of precision medicine, the plan of
the project, and data sharing policies, we asked about the need
for the RCP-PMR (Figure 1A). Most respondents (94.5%) agreed
on the need to implement the study and, among variables, men
(95.0%), older adults (older than 50, 96.1%), those with a higher
education (high school [95.6%], and college and more [94.6%]),
and current SNS users (95.3%) highly supported implementing
the study (Table 2).
Adjusting for the other factors in Tables 1, 2 showed no
significant differences between genders, region groups, and
household income groups by a multiple logistic regression
treating the need of the RCP-PMR as a binary independent
variable. Younger age (20–29 [p = 0.015]) and lower education
level (less than middle school [p = 0.021]) were independently
associated with lower levels of support for the study. The SNS
non-user group was significantly associated with higher levels of
support for the study (p = 0.019).
Willingness to Participate in the Study
When asked about their intention to participate
in the project, 83.5% of respondents said they
would participate and 16.5% said they would
not (Figure 1B).
Adjusting for the other factors in Table 1, age 20–49 (20–
29: p = 0.001; 30–39: p = 0.002; 40–49: p = 0.047) and lower
household income (< \2,000,000: p < 0.0001; \2,000,000 –
\3,990,000: p< 0.0001) were independently associated with lower
levels of willingness to participate in the study (Table 2). As
a group, those who did not have experience with SNS were
significantly more likely to say they would participate in the study
if asked (p = 0.039).
Concerns About Participating in the
Study
Among 247 respondents who said they would not participate
in the study, we asked about the reasons why they have no
intention to participate in the study. Of the respondents, 94
(38.1%) expressed concerns about it being time consuming
or a hassle. The leakage of personal information was a
concern for 83 respondents (33.6%), and 62 respondents
(25.1%) were concerned about the lack of returning benefits
of participation.
Willingness to Provide Personal
Information and Samples for the Study
We asked all respondents, including those who said they
would not participate, about their willingness to provide
various types of samples and data to this project (Figure 2).
Most respondents replied that they would provide clinical
information (n = 1,311, 87.4%), samples (n = 1,328,
88.5%), genetic information (n = 1,268, 84.5%), and data
on lifestyle (n = 1,349, 89.9%) and would link their data
with existing national statistics from the Meteorological
Administration and the Ministry of Environment (85.9%).
Many of the respondents who would not provide specimens
or personal health information were concerned about
personal information leakage and privacy violations. Most
respondents had a positive attitude toward providing
specimens and information, and 84.5% to 89.9% of
participants said they would provide certain types of samples
and information.
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FIGURE 2 | Willingness to provide personal information and samples if asked.
FIGURE 3 | Willingness to share personal information and samples with researchers.
Appropriate Research Institute to
Undertake the Study
We asked all respondents about their opinion on what
type of research institute would be suitable in initiating
the RCP-PMR. The majority of respondents (66.9%)
said that it should be carried out by government
research institutes. Less than 20% of respondents agreed
that the study should be undertaken by government-
funded research institutes (19.7%), other non-profit
institutes (8.8%), and industry and private research
institutes (4.5%).
Using the Collected Samples and
Personal Information
The RCP-PMR plans to authorize qualified researchers to
use data and specimens collected from cohort participants
to perform various research activities. In the questionnaire,
we asked about their willingness regarding the range
of researchers allowed to use the personal information
and samples provided by participants. Most respondents
responded negatively to their specimens and information
being used by researchers who are not directly involved
in the RCP-PMR. The approval rate for their own data
being used by the government researchers running this
project was quite high (88%), but the approval rates
for its use by other government researchers (22.3%),
domestic university researchers (22.1%), pharmaceutical
researchers (15.1%), and foreign researchers (6.1%) were all
low (Figure 3).
Participation Benefits
Respondents were asked about the importance of incentives
behind their decision of whether to participate. Respondents
said incentives are very important (31.4%) or rather important
(61.0%). The incentives for participation were receiving health
information (80.2%), monetary compensation less than 50,000
KRW (about 42 USD) per year (51.4%), and smart devices
(41.3%) (Figure 4A). When asked about the information
they wanted to receive, laboratory results (cholesterol, blood
sugar, etc.) was the highest (73.7%), followed by health
information based on family history and genetic testing
(67.7%), genetic testing results (66%), health-related research
results that use their own information (49.8%), nutrition
information (48.9%), health information based on lifelog
results (46.7%), and environment-based health information
(38.9%) (Figure 4B).
Participation in Decision-Making
In large-scale cohort projects that receive a variety of samples and
information, it is important to communicate with participants
to identify stakeholder needs. Participants were asked whether
the opportunity to comment on the project design or operation
was important or not, and most respondents (89.7%) said it
was important. When we subsequently asked about the phases
of the study in which they wanted to participate in decision-
making, the rates of participation in each phase were all under
40%. They mainly wanted to be involved in three phases:
the questionnaire development and design of personal data
collection (39.6%), study participant recruitment (38.9%), and
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FIGURE 4 | Participation benefits: Willingness to participate based on benefits (A) and desired health information to receive (B).
FIGURE 5 | Desired participation in decision making of the study by phase.
deciding which research projects will use the collected data
(37.0%) (Figure 5).
Change in Perception Regarding Project
Participation
We expected that participants who completed the survey would
have a better understanding of the project, and this was assumed
to have an impact on their willingness to participate in the project.
In order to confirm the change in perception regarding project
participation, near the end of the survey, respondents were once
again asked, “Would you participate in the project?” Of the
respondents, 83.5% said they would participate in the project, and
their intention to participate in the project was almost unchanged
from the beginning to the end of the survey.
DISCUSSION
A large-scale research cohort study is important to ensure that
the RCP-PMR develops in a manner that respects public values
and interests as well as the instrumental goals of recruiting and
retaining participants. We conducted a survey of Korean adults
who are potential participants to understand their opinions on
the RCP-PMR. Five points of discussion regarding the results
analysis are presented below.
The first point is regarding the public attitude toward the
citizen participation cohort model for precision medicine. Our
survey results showed that 94.5% of participants answered
that we need this project, which is 15.5% higher than
the Kaufman et al. (2016) study in the United States
(Kaufman et al., 2016). The intention to participate is
very high (83.5%), which is much higher than that of the
Kaufman et al. study (54%) (Kaufman et al., 2016). We
can extrapolate that this result is because of the sense
of the nationalism of and the familiarity with cutting-edge
technology among Koreans. Kim (2007) showed that the
majority of participants had very positive attitudes toward
the life sciences industry as the most important pillar of the
South Korean economy (Kim, 2007) and Okita et al. explained
that a sense of responsibility to their families and society
may have a positive impact on increasing the willingness
to participate in genomics research in Japan (Okita et al.,
2018). Bak and Kim (2016) also provided evidence that
the higher the trust in scientific expertise, the higher the
level of public support for social problem-solving research
in South Korea (Bak and Kim, 2016). This positive attitude
of the general public also corresponds with the Ishiyama
et al. (2008) finding that 69.4% of Japanese participants
favored the promotion of genomic studies related to medicine
(Ishiyama et al., 2008).
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More specifically, this result also showed that a lower level of
support for the project is associated with lower education levels,
consistent with Okita et al. in Japan and a focus group study
in China (Chen et al., 2013; Okita et al., 2018). To establish
strategies to recruit and retain participants in the research
program, it is essential to obtain more evidence on prejudice
against or misconceptions of this project results from low levels
of genomic literacy and to explore favorable ways of knowledge
translation and transfer in order to identify appropriate health
and educational interventions (Etchegary et al., 2013; Nakamura
et al., 2017). On the other hand, those who do not have experience
with SNS were significantly more likely to agree on the need to
implement the study and answered that they would participate in
the study if asked. While SNS was known as a potential source
for participant recruitment and research data for those who are
supportive toward this kind of large-scale precision medicine
project (Reaves and Bianchi, 2013), this survey result requires
more elaborative strategy to encourage them to use SNS and
to improve their knowledge about SNS. The evidence can also
support the development of educational and awareness programs
to familiarize people with genomics and health beyond the scope
of the RCP-PMR (Reaves and Bianchi, 2013).
Second, 24.7% of the respondents who were not willing
to participate said they would get involved if they had better
protection from privacy leakage and if personalized health
services were provided. Gaskell et al. in Europe provided a
possible reason for participants’ privacy concern that people
explicitly expressed that privacy violations are an issue not only
in biobanks but also in wider society (Dorey et al., 2018).
A recent South Korean governmental report also supports
the finding of Gaskell et al. – 4.6% of 4,000 internet users
experienced information security incidents, and 97.3% were
aware of the importance of personal information security in
2018 (Gaskell et al., 2013). Health information security, such as
leakage of personal information in the National Health Insurance
Corporation database in the ROK, remains a serious issue
(Korean Internet & Security Agency, 2018). Although it is crucial
to utilize the RCP-PMR database for data sharing in research
and commercial sectors, this emerging public view of privacy
protection suggests that a well-established model for privacy
protection and communication with the public are needed.
Third, regarding benefits of participation, 80.2% of
respondents wanted health information including health
examination and genetic testing results as an appropriate
compensation for participating in the project. People in
South Korea already receive health results from regular medical
checkups such as general health exams and cancer screenings,
which are covered by the national health insurance program, as
they are in Japan, Taiwan, and Singapore. However, the possibility
of receiving genetic testing results in particular could be the
reason participants preferred a return of health information to
other forms of compensation. This public interest in return of
results should be specifically implemented in the RCP-PMR.
Next, in terms of public willingness to allow different types of
researchers to use their data and samples, a significant gap was
found between researchers running the program and researchers
outside the program, particularly private companies. This project
will be carried out by researchers who are qualified to research
various specimens and information provided by the participants.
More than 85% of respondents said they would provide a
variety of specimens and personal information, and 88.0% of
participants agreed that government researchers conducting the
project should be able to use their specimens and information.
However, they had a negative attitude toward its use by other
government researchers, non-government researchers such as
private companies, and foreign researchers. The United States
survey showed that participants agreed to use various researchers
such as researchers at the National Institutes of Health (79%),
other government researchers (44%), university researchers in
the United States (71%), pharmaceutical or drug company
researchers (52%), and university researchers in other countries
(39%) (Kaufman et al., 2016). In the ROK, however, only
6.1% – 22.3% of the participants agreed to have their data
used by researchers other than the government researchers
running the project. This result suggests that sharing the provided
samples and information with non-government researchers such
as private companies may reduce willingness to participate.
For the success of the project, however, it is necessary to
communicate with the lay public as well as the RCP-PMR
participants to improve their understanding of the purpose of
the project and how data sharing can contribute to disease
research and prevention.
Finally, in terms of the citizen partnership model in the
decision-making process of the RCP-PMR, the findings addressed
a gap between the 89.7% of respondents willing to participate
generally in the decision-making process of the RCP-PMR
and their low response rate of willingness to participate in
each individual study phase (16.7–39.6%). We can interpret
that researchers in Korea did not consider the engagement
of research participants in the decision-making process of
biobanking or personalized medicine research, so the lay
public were not experienced in how to involve themselves in
the decision-making process of this kind of research project.
Communication with civil society and patient organizations at
various stages of the research would be important in improving
understanding and reaching consensus to achieve the goals of
precision medicine.
This study also found that around 40% of respondents would
want to provide their opinions on questionnaire development
and data collection (39.6%), recruitment (38.9%), and approval
of research for data use (37.0%). In particular, this finding is
consistent with the United States study, which found that the
respondents wanted to be involved in helping decide what kinds
of research are appropriate (45%) and what to do with the study
results (45%) (Kaufman et al., 2016).
LIMITATIONS
The findings of this study have to be seen in light of some
important limitations. First, the participants highly supported the
RCP-PMR but the results may not reflect actual participation
rate of South Korean population. The full response rate from
the invitation is 2.9%, so the survey results do not reflect actual
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willingness to participate. In addition, all invited participants
were on panels of a survey firm, so they possibly responded more
favorably than the general population.
Second, this survey focused on the social acceptance of the
implementation of and participation in the RCP-PMR, meaning
that participants’ perceptions of what can be derived from this
study were not examined. For instance, ethical concerns over
sharing genomic data, including that of the patient’s family
members, is an emerging issue in East Asian countries (Johnsson
et al., 2010; Yoshizawa et al., 2017). Families have played
significant roles in genetic research, and their value is re-
illuminated in the era of genomic medicine. It is important to
make progress in data sharing while simultaneously protecting
the privacy and interests of patients and families and returning
its benefits to them (Yoshizawa et al., 2017). More empirical
evidence to identify interrelated and cross-cultural factors of
the social acceptance of government-led biomedical research
is also required.
In addition, public awareness of the risks of health-related
data sharing has not been fully investigated in this research.
The perceptions of potential risks of data sharing are influenced
by attitudes to genomic data sharing (Takashima et al., 2018).
The applications of health-related data sharing on the grounds
of research and public interest, without due regard for the
perspective of patients and the lay public, could run the
risk of fostering distrust toward healthcare data collection
(Chen et al., 2013). Further studies to investigate the issues,
such as discrimination, are essential to promote voluntary
participation by the public.
Finally, our finding that lower levels of education population
correspond to lower levels of support for the project is possibly
associated with genomics-related literacy. However, this study
is limited by the fact that the survey participants do not know
how much they understand about the project and genomics and
responded to the survey based on the guidance given. Thus, as
discussed above, we suggest further empirical studies to evaluate
genomics-related literacy as a basis of establishing health and
educational strategies.
CONCLUSION
These survey results will influence the policy development of the
precision medicine national cohort program in South Korea. We
found that the need for the project, the willingness to participate
in the project, and the willingness to provide specimens and
information to the project are higher than the results of the
United States and Japan. This survey also found a strong
willingness of the public to participate in the decision-making
process of the RCP-PMR. However, more importantly, this
survey also revealed that participants who have negative attitudes
toward the RCP-PMR are concerned about privacy violations and
the majority of participants disagreed with specimen and data
sharing with researchers other than the government researchers
who run the project.
For the success of this national project, such findings will
determine the public engagement policy for precision medicine
in South Korea. As a crucial point, the policy will focus on
communicating with the general public and patients how the
project and sharing of data with other researchers can help
healthcare. This project will also establish a system of the
governance that respects the opinions of various stakeholders,
including civil society organizations, patient groups, and
researchers in the project planning and execution.
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